Lomaia, E. G., Romanova, E. G., Sbityakova, E. I., & Zaritskiy, A. Y. Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia. ABV-press.
Chicago Style (17th ed.) CitationLomaia, E. G., E. G. Romanova, E. I. Sbityakova, and A. Yu Zaritskiy. Efficacy and Safety of Tyrosine Kinase Inhibitors (dasatinib, Nilotinib) in the Treatment of Chronic Phase Chronic Myeloid Leukemia. ABV-press.
MLA (9th ed.) CitationLomaia, E. G., et al. Efficacy and Safety of Tyrosine Kinase Inhibitors (dasatinib, Nilotinib) in the Treatment of Chronic Phase Chronic Myeloid Leukemia. ABV-press.
Warning: These citations may not always be 100% accurate.